Literature DB >> 18620988

Amyloidosis of seminal vesicles and ejaculatory ducts: a histologic analysis of 21 cases among 447 prostatectomy specimens.

Keun Hong Kee1, Mi Ja Lee, Steve S Shen, Jae Hee Suh, Ok-Jun Lee, Hyun Y Cho, Alberto G Ayala, Jae Y Ro.   

Abstract

To investigate the incidence of amyloidosis of seminal vesicles and ejaculatory system including ejaculatory ducts and vasa deferentia, we reviewed the whole mount sections of 447 radical prostatectomy specimens removed for prostatic cancer, including 273 cases from the United States and 174 cases from Korea. Of these, 21 cases (4.7%) showed amyloidosis in seminal vesicles, vasa deferentia, and in ejaculatory ducts. Ten of these (3.7%) cases were from the United States and 11 cases (6.3%) from Korea. The patients' age ranged from 51 to 79 years (mean, 66.1 years). Amyloid deposition was found in 5 patients in the sixth decade (3.4%), 9 patients in the seventh decade (4.7%), and 7 patients in the eighth decade (9.3%). At the seventh decade of life, the Korean patients showed a higher incidence (8.3%) than American patients (2.5%), but other age groups showed no difference. All cases showed bilateral involvement of the seminal vesicles and ejaculatory systems. The deposits of amyloid tended to be nodular and affected the subepithelial region of seminal vesicles, vasa deferentia, and ejaculatory ducts. There was no amyloid deposit around blood vessels or in the prostatic parenchyma. Localized amyloidosis of the ejaculatory system involves not only the seminal vesicles but also the vasa deferentia and the ejaculatory ducts. The vessels or prostatic stroma are not part of this process. Amyloidosis develops subepithelially spreading to include the wall of these organs and appears to be related to advanced age. The incidence of amyloidosis of the ejaculatory system in Korean patients was higher than in US patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620988     DOI: 10.1016/j.anndiagpath.2007.12.004

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  6 in total

1.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

2.  Seminal Tract Amyloidosis: Synchronous Amyloidosis of the Seminal Vesicles, Deferent Ducts and Ejaculatory Ducts.

Authors:  Lea Rath-Wolfson; Golan Bubis; Shmuel Shtrasburg; Asaf Shvero; Rumelia Koren
Journal:  Pathol Oncol Res       Date:  2017-01-17       Impact factor: 3.201

Review 3.  Antimicrobial properties of amyloid peptides.

Authors:  Bruce L Kagan; Hyunbum Jang; Ricardo Capone; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Ruth Nussinov
Journal:  Mol Pharm       Date:  2011-11-29       Impact factor: 4.939

4.  Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies--are routine investigations for systemic amyloidosis warranted?

Authors:  Zichu Yang; Alexander Laird; Ashley Monaghan; Morag Seywright; Imran Ahmad; Hing Y Leung
Journal:  Asian J Androl       Date:  2012-12-10       Impact factor: 3.285

5.  Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.

Authors:  William A Eimer; Deepak Kumar Vijaya Kumar; Nanda Kumar Navalpur Shanmugam; Alex S Rodriguez; Teryn Mitchell; Kevin J Washicosky; Bence György; Xandra O Breakefield; Rudolph E Tanzi; Robert D Moir
Journal:  Neuron       Date:  2018-07-11       Impact factor: 17.173

6.  Localized amyloidosis of the epididymis: a previously unreported phenomenon.

Authors:  Lucio Díaz-Flores; Ricardo Gutiérrez; Ma Del Pino García; Manuel Jose Gayoso; Jose Luis Carrasco; Lucio Díaz-Flores; Hugo Álvarez-Argüelles
Journal:  Diagn Pathol       Date:  2017-08-04       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.